Selexipag for Pulmonary Arterial Hypertension: Dosage & Benefits

Key Points About Selexipag for Pulmonary Arterial Hypertension Treatment

Selexipag is a medication used to treat pulmonary arterial hypertension (PAH) and related conditions. It works by relaxing the blood vessels in the lungs, making it easier for the heart to pump blood. Selexipag helps improve exercise capacity and slows the progression of PAH. It’s essential to take this medication exactly as prescribed and consult your doctor before making any changes to your dose.

Names of Selexipag Medication

US Brand Name: Uptravi

Generic Name: Selexipag

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. In this case, Selexipag is the generic name.

Pharmacologic Category of Selexipag

Selexipag belongs to a class of medications known as prostacyclin receptor agonists. Other medications in this category include:

1. Treprostinil (Orenitram, Remodulin, Tyvaso)
2. Epoprostenol (Flolan, Veletri)
3. Iloprost (Ventavis)

Selexipag Dosage for Pulmonary Arterial Hypertension and Related Conditions

Selexipag is prescribed for various conditions related to pulmonary hypertension. Always follow your doctor’s dosing instructions and never adjust your dose without consulting your healthcare provider. If needed, you can schedule a telemedicine appointment with one of our providers.

Selexipag Dosage for Pulmonary Arterial Hypertension (PAH)

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Heart Failure

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Left Heart Disease

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Sickle Cell Disease

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Idiopathic Pulmonary Fibrosis

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Connective Tissue Disease

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Congenital Heart Disease

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for HIV-Associated Pulmonary Hypertension

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage for Portal Hypertension

Initial Dose: 200 mcg twice daily

Maintenance Dose: The dose may be increased by 200 mcg twice daily at weekly intervals, based on tolerance, up to a maximum of 1600 mcg twice daily.

Duration of Treatment: Long-term, as prescribed by your doctor.

Selexipag Dosage Forms and Strengths

Selexipag is available in the following forms and strengths:

1. Tablets: 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg

Selexipag Administration Instructions

Selexipag should be taken orally, with or without food. It’s important to take the medication at the same time each day. If you miss a dose, take it as soon as you remember, unless it’s close to your next dose. Do not double up on doses. Always follow your doctor’s instructions, and consult your healthcare provider if you have any questions or concerns.

Selexipag Contraindications

A contraindication is a specific situation where a drug should not be used because it may cause harm. Selexipag has certain contraindications, meaning it’s not safe for everyone. Below are the main reasons why Selexipag may be contraindicated:

1. Severe liver disease: Selexipag is processed by the liver. If your liver isn’t functioning properly, the medication may build up in your body, leading to harmful side effects.
2. Allergic reaction to Selexipag or its ingredients: If you’ve had an allergic reaction to Selexipag, taking it again could cause serious symptoms like difficulty breathing, swelling, or rash.
3. Severe low blood pressure (hypotension): Selexipag can lower blood pressure, so if you already have very low blood pressure, this medication could worsen it, leading to dizziness, fainting, or even shock.

If you have any of these conditions, it’s important to talk to your healthcare provider before starting Selexipag. Our telemedicine providers are available to discuss your medical history and determine if Selexipag is right for you.

Drug to Drug Interactions with Selexipag

Selexipag can interact with other medications, potentially increasing side effects or reducing the effectiveness of either drug. It’s important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Below are some common medications that may interact with Selexipag:

1. Rifampin (Rifadin): This antibiotic can decrease Selexipag’s effectiveness by speeding up how quickly your body metabolizes it.
2. Ketoconazole (Nizoral): This antifungal can raise Selexipag levels in your body, increasing the risk of side effects.
3. Clopidogrel (Plavix): A blood thinner that may heighten the risk of bleeding when taken with Selexipag.
4. Warfarin (Coumadin): Another blood thinner that can further increase the risk of bleeding when combined with Selexipag.

Always consult your healthcare provider before starting or stopping any medications. If you have concerns about drug interactions, our telemedicine providers can help you manage your medications safely.

Selexipag and Pregnancy: Is It Safe?

Is it safe to take Selexipag during pregnancy? The safety of Selexipag in pregnancy has not been well established. Animal studies suggest potential risks to the fetus, and there is limited data on its use in pregnant women. As a result, Selexipag is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks. If you are pregnant or planning to become pregnant, discuss this with your healthcare provider to explore safer alternatives.

Selexipag while Breastfeeding: What You Need to Know

Is it safe to take Selexipag while breastfeeding? It is unknown whether Selexipag passes into breast milk. Due to the potential for serious side effects in a nursing infant, it is recommended that women either discontinue breastfeeding or avoid taking Selexipag. If you are breastfeeding, talk to your healthcare provider about the risks and benefits of continuing this medication.

Estimated Cost of Selexipag Medication

The estimated cost of a 30-day supply of Selexipag without insurance can vary. Using a GoodRx coupon, the cost typically ranges from $8,000 to $9,000 for a 30-day supply, depending on the dosage and pharmacy. Prices may fluctuate, so it’s a good idea to check GoodRx or other discount programs for the most current prices.

Possible Alternatives to Selexipag

If Selexipag is not suitable for you, or if you are looking for alternative treatments, there are other options available depending on your specific condition. Below are some alternatives for the conditions Selexipag is commonly used to treat:

1. Pulmonary arterial hypertension (PAH): Alternatives include medications like bosentan (Tracleer) or sildenafil (Revatio), along with lifestyle changes such as regular exercise and a low-sodium diet. Always consult your healthcare provider before making any changes.
2. Chronic thromboembolic pulmonary hypertension (CTEPH): Riociguat (Adempas) is another medication option. In some cases, surgery may be considered.
3. Heart failure: Medications like ACE inhibitors, beta-blockers, or diuretics may be used. Lifestyle changes such as reducing salt intake, exercising, and quitting smoking can also help.
4. Left heart disease: Treatment typically focuses on managing heart failure symptoms with medications like diuretics or beta-blockers.
5. Sickle cell disease: Hydroxyurea or blood transfusions may be used to manage symptoms. Staying hydrated and avoiding extreme temperatures can also help.
6. Idiopathic pulmonary fibrosis: Medications like pirfenidone (Esbriet) or nintedanib (Ofev) may be prescribed. Pulmonary rehabilitation and oxygen therapy are other options.
7. Connective tissue disease: Treatment may include immunosuppressants or corticosteroids to manage symptoms.
8. Congenital heart disease: Depending on the severity, treatment may involve medications, surgery, or lifestyle changes.
9. HIV-associated pulmonary hypertension: Antiretroviral therapy (ART) is the main treatment, along with medications to manage PAH symptoms.
10. Portal hypertension: Beta-blockers or procedures to reduce blood pressure in the portal vein may be recommended.

It’s important to discuss any alternative treatments with your healthcare provider before making changes to your treatment plan. Our telemedicine providers are available to help you explore these options and find the best course of action for your health.

Recent Updates on Selexipag Research

Recent studies on Selexipag continue to explore its long-term effectiveness and safety in treating pulmonary arterial hypertension (PAH). A 2021 study published in the journal Chest found that Selexipag significantly reduced the risk of disease progression in PAH patients over a 3-year period. Additionally, ongoing clinical trials are investigating the use of Selexipag in combination with other PAH medications to optimize treatment outcomes.

Researchers are also exploring the potential benefits of Selexipag in other forms of pulmonary hypertension, such as chronic thromboembolic pulmonary hypertension (CTEPH). While more data is needed, early results are promising. If you are interested in learning more about the latest research or participating in a clinical trial, consult your healthcare provider.

James Kingsley

Learn More